- Home
- Publications
- Publication Search
- Publication Details
Title
Why is there no biosimilar of Erbitux®?
Authors
Keywords
-
Journal
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Volume -, Issue -, Pages 115544
Publisher
Elsevier BV
Online
2023-06-22
DOI
10.1016/j.jpba.2023.115544
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlative N-Glycan and Charge Variant Analysis of Cetuximab Expressed in Murine, Chinese Hamster and Human Expression Systems
- (2022) Anne Trappe et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Antibodies to watch in 2023
- (2022) Hélène Kaplon et al. mAbs
- Barriers To US Biosimilar Market Growth: Lessons From Biosimilar Patent Litigation
- (2021) Victor L. Van de Wiele et al. HEALTH AFFAIRS
- Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective
- (2021) Pekka Kurki et al. DRUGS
- Quantitative N-Glycan Profiling of Therapeutic Monoclonal Antibodies Performed by Middle-Up Level HILIC-HRMS Analysis
- (2021) Bastiaan L. Duivelshof et al. Pharmaceutics
- A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck – the RESGEX study
- (2021) K. Klinghammer et al. ESMO Open
- Comparative Elucidation of Cetuximab Heterogeneity on the Intact Protein Level by Cation Exchange Chromatography and Capillary Electrophoresis Coupled to Mass Spectrometry
- (2020) Florian Fussl et al. ANALYTICAL CHEMISTRY
- Therapeutic Fc‐fusion proteins: Current analytical strategies
- (2020) Bastiaan L. Duivelshof et al. JOURNAL OF SEPARATION SCIENCE
- Anion exchange chromatography – Mass spectrometry for monitoring multiple quality attributes of erythropoietin biopharmaceuticals
- (2020) Guusje van Schaick et al. ANALYTICA CHIMICA ACTA
- CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial
- (2019) Yuankai Shi et al. Cancer Communications
- Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications
- (2019) Bastiaan L. Duivelshof et al. ANALYTICA CHIMICA ACTA
- 68PA novel anti-EGFR antibody HLX07 for potential treatment of squamous cell carcinoma of the head and neck
- (2019) M M Hou et al. ANNALS OF ONCOLOGY
- Analysis of cetuximab N-Glycosylation using multiple fractionation methods and capillary electrophoresis mass spectrometry
- (2019) Csaba Váradi et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Development of Comprehensive Online Two-Dimensional Liquid Chromatography/Mass Spectrometry Using Hydrophilic Interaction and Reversed-Phase Separations for Rapid and Deep Profiling of Therapeutic Antibodies
- (2018) Dwight R. Stoll et al. ANALYTICAL CHEMISTRY
- Market watch: Top drugs and companies by sales in 2017
- (2018) Lisa Urquhart NATURE REVIEWS DRUG DISCOVERY
- Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals
- (2018) Therese Wohlschlager et al. Nature Communications
- Comparative safety assessments of the biosimilar APZ001 and Erbitux in pre-clinical animal models
- (2018) Xiaofei Wang et al. Acta Cirurgica Brasileira
- Orthogonal Middle-up Approaches for Characterization of the Glycan Heterogeneity of Etanercept by Hydrophilic Interaction Chromatography Coupled to High-Resolution Mass Spectrometry
- (2018) Valentina D’Atri et al. ANALYTICAL CHEMISTRY
- Optimizing separations in online comprehensive two-dimensional liquid chromatography
- (2017) Bob W.J. Pirok et al. JOURNAL OF SEPARATION SCIENCE
- Variability of intended copies for etanercept (Enbrel®): Data on multiple batches of seven products
- (2017) Brian Hassett et al. mAbs
- Biosimilars: Implications for Clinical Practice
- (2017) Robert M. Rifkin et al. Journal of Oncology Practice
- Two-Dimensional Liquid Chromatography: A State of the Art Tutorial
- (2016) Dwight R. Stoll et al. ANALYTICAL CHEMISTRY
- Potential of hydrophilic interaction chromatography for the analytical characterization of protein biopharmaceuticals
- (2016) Aurélie Periat et al. JOURNAL OF CHROMATOGRAPHY A
- Evaluation of the structural, physicochemical, and biological characteristics of SB4, a biosimilar of etanercept
- (2016) Ick Hyun Cho et al. mAbs
- Comparison of originator and biosimilar therapeutic monoclonal antibodies using comprehensive two-dimensional liquid chromatography coupled with time-of-flight mass spectrometry
- (2016) Matthew Sorensen et al. mAbs
- Biosimilars: A consideration of the regulations in the United States and European union
- (2016) Justin Daller REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies
- (2016) Evelien Moorkens et al. Frontiers in Pharmacology
- Glycoform Separation and Characterization of Cetuximab Variants by Middle-up Off-Line Capillary Zone Electrophoresis-UV/Electrospray Ionization-MS
- (2015) Michael Biacchi et al. ANALYTICAL CHEMISTRY
- Direct Identification of Rituximab Main Isoforms and Subunit Analysis by Online Selective Comprehensive Two-Dimensional Liquid Chromatography–Mass Spectrometry
- (2015) Dwight R. Stoll et al. ANALYTICAL CHEMISTRY
- Rapid Preparation of Released N-Glycans for HILIC Analysis Using a Labeling Reagent that Facilitates Sensitive Fluorescence and ESI-MS Detection
- (2015) Matthew A. Lauber et al. ANALYTICAL CHEMISTRY
- Biosimilar: what it is not
- (2015) Fernando de Mora BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Fc glycans of therapeutic antibodies as critical quality attributes
- (2015) Dietmar Reusch et al. GLYCOBIOLOGY
- Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies
- (2015) Alain Beck et al. JOURNAL OF MASS SPECTROMETRY
- Glycan analysis of therapeutic glycoproteins
- (2015) Lei Zhang et al. mAbs
- Regulatory And Cost Barriers Are Likely To Limit Biosimilar Development And Expected Savings In The Near Future
- (2014) Henry G. Grabowski et al. HEALTH AFFAIRS
- Approval of the first biosimilar antibodies in Europe
- (2013) Alain Beck et al. mAbs
- Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques
- (2013) Daniel Ayoub et al. mAbs
- An innovative approach for the characterization of the isoforms of a monoclonal antibody product
- (2012) Shanmuuga Sundaram et al. mAbs
- Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumors
- (2011) Chong Wang et al. mAbs
- Biosimilar, biobetter and next generation therapeutic antibodies
- (2011) Alain Beck mAbs
- European Medicines Agency workshop on biosimilar monoclonal antibodies
- (2010) Janice M. Reichert et al. mAbs
- Cell culture processes for monoclonal antibody production
- (2010) Feng Li et al. mAbs
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
- (2008) Christine H. Chung et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started